Joel Greenblatt’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-10,720
Closed -$368K – 1879
2026
Q2
$368K Buy
+10,720
New +$324K ﹤0.01% 1590
2024
Q2
– Sell
-14,932
Closed -$493K – 1421
2024
Q1
$493K Buy
+14,932
New +$465K 0.01% 1058

Other funds holding BEAM

Joel Greenblatt's BEAM Position: Q3 2026 in Review

Joel Greenblatt sold out of Beam Therapeutics (BEAM) in Q3 2026, closing a stake of 10,720 shares — an estimated $368K sold.

Joel Greenblatt first reported a position in BEAM in Q1 2024 and held it in 2 quarters. The position peaked at $493K in Q1 2024. 261 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.

  • Joel Greenblatt reported no remaining Beam Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Joel Greenblatt sold 10,720 Beam Therapeutics shares in Q3 2026, an estimated $368K.
  • Joel Greenblatt first reported a position in Beam Therapeutics in Q1 2024 and held it in 2 quarters.
  • Joel Greenblatt's Beam Therapeutics position peaked at $493K in Q1 2024.
  • 261 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.

Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.